Modified mucoadhesive polymers for the peroral administration of mainly elastase degradable therapeutic (poly)peptides

Journal of Controlled Release

Volumn 47, Issue 2, 1997, Pages 113-121

  Bernkop Schnürch, Andreas ^a   Schwarz, Gerit H ^a   Kratzel, Martin ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Elastase; Elastatinal; Luminal degradation; Mucoadhesive polymers; Peroral administration of (poly)peptides

Indexed keywords

CARBOXYMETHYLCELLULOSE; ELASTASE; ELASTATINAL; POLYACRYLIC ACID; POLYMER;

ADHESION; ANIMAL TISSUE; ARTICLE; DOG; DRUG CONJUGATION; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; ENZYME ASSAY; INTESTINE MUCOSA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0030943636     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)01627-1     Document Type: Article

References (27)

1. A. Pusztai, Transport of proteins through the membranes of the adult gastro- intestinal tract - a potential for drug delivery? Adv. Drug Deliv. Rev. 3 (1989) 215-228.
2. A. Bernkop-Schnürch and R. Fragner, Investigations into the diffusion behaviour of polypeptides in native intestinal mucus with regard to their peroral administration, Pharm. Sci. 2 (1996) 361-363.
3. J.F. Woodley, Enzymatic barriers for GI peptide and protein delivery, Crit. Rev. Ther. Drug 11 (1994) 61-95.
4. A.F. Bristow, The current status of therapeutic peptides and proteins, in: R.C. Hider and D. Barlow (Eds.), Polypeptide and Protein Drugs - Production, Characterization and Formulation, Ellis Horwood, Chichester, UK, 1991, pp. 54-69.
5. G.J. Russel-Jones and H.J. de Aizpurua, Vitamin B12: a novel carrier for orally presented antigens, Proc. Int. Symp. Control Rel. Bioact. Mater. 15 (1988) 142-143.
6. I. Morishita, M. Morishita, K. Takayama, Y. Machida and T. Nagai, Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats, Int. J. Pharm. 78 (1992) 9-16.
7. M. Morishita, I. Morishita, K. Takayama, Y. Machida and T. Nagai, Novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradation, Int. J. Pharm. 78 (1992) 1-7.
8. A.T. Florence, A.M. Hillery, N. Hussain and P.U. Jani, Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate, J. Control. Release 36 (1995) 39-46.
9. J. Mestecky, Z. Moldoveanu, M. Novak, W.-Q. Huang, R.M. Gilley, J.K. Staas, D. Schafer and R.W. Compans, Biodegradable microspheres for the delivery of oral vaccines, J. Control. Release 28 (1994) 131-141.
10. R.R.C. New, R.D.G. Theakston, O. Zumbuehl, D. Iddon and J. Friend, Liposomal immunisation against snake venoms, Toxicon 21 (1985) 215-219.
11. P. Kopeckova, R. Rathi, S. Takada, B. Rihova, M.M. Berenson and J. Kopecek, Bioadhesive N-(2-hydroxypropyl)methacrylamide copolymers for colon-specific drug delivery, J. Control. Release 28 (1994) 211-222.
12. H.E. Junginger, Bioadhesive polymer systems for peptide delivery, Acta Pharm. Technol. 36 (1990) 110-126.
13. C.-M. Lehr, Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract, Crit. Rev. Ther. Drug 11 (1994) 119-160.
14. A. Bernkop-Schnürch and K. Dundalek, Novel bioadhesive drug delivery system protecting (poly)peptides from gastric enzymatic degradation, Int. J. Pharm. 138 (1996) 75-83.
15. T. Yagi, K. Ishizaki and H. Takebe, Cytotoxic effects of protease inhibitors on human cells. 2. Effect of elastatinal, Cancer Lett. 10 (1980) 301-307.
16. K. Ikesue, P. Kopeckova and J. Kopecek, Degradation of proteins by guinea pig intestinal enzymes, Int. J. Pharm. 95 (1993) 171-179.
17. H.S. Chńg, H. Park, P. Kelly and J.R. Robinson, Bioadhesive polymers as platforms for oral controlled drug delivery. II: Synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers, J. Pharm. Sci. 74 (1985) 399-405.
18. J.V. Staros, R.W. Wright, and D.M. Swingle, Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions, Anal. Biochem. 156 (1986) 220-222.
19. S.A. Mortazavi and J.D. Smart, An investigation of some factors influencing the in vitro assessment of mucoadhesion, Int. J. Pharm. 116 (1995) 223-230.
20. B. Proksa, J. Adamcova, M. Strudikova and J. Fuska, Metabolites of Pseudevernia furfuracea (L.) Zopf, and their inhibition potential of proteolytic enzymes, Pharmazie 49 (1994) 282-283.
21. H.L. Lueßen, J.C. Verhoef, G. Borchard, C.-M. Lehr, A.G. de Boer and H.E. Junginger, Mucoadhesive polymers in the peroral peptide drug delivery: 2. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin, Pharm. Res. 12 (1995) 1293-1298.
22. J.P.F. Bai, L.L. Chang and J.H. Guo, Effects of polyacrylic polymers on the degradation of insulin and peptide drugs by chymotrypsin and trypsin, J. Pharm. Pharmacol. 48 (1996) 17-21.
23. L. Stryer, Biochemistry, W.H. Freeman and Company, New York, NY, 1988.
24. K. Park and J.R. Robinson, Bioadhesive polymers as platforms for the oral controlled drug delivery: method to study bioadhesion, Int. J. Pharm. 19 (1984) 107-127.
25. C.-M. Lehr, J.A. Bouwstra, W. Kok, A.G. de Boer, J.J. Tukker, J.C. Verhoef, D.D. Breimer and H.E. Junginger, Effects of the mucoadhesive polymer polycarbophil on the intestinal absorption of a peptide drug in the rat, J. Pharm. Pharmacol. 44 (1992) 402-407.
26. A. Bernkop-Schnürch and N.C. Göckel, Development and analysis of a polymer protecting from luminal enzymatic degradation caused by α-chymotrypsin, Drug Dev. Ind. Pharm. (1996), accepted for publication.
27. H.L. Lueßen, B.J. de Leeuw, D. Pérard, C.-M. Lehr, A.G. de Boer, J.C. Verhoef and H.E. Junginger, Mucoadhesive polymers in peroral peptide drug delivery. I. Influence of mucoadhesive excipients on the proteolytic activity of intestinal enzymes, Eur. J. Pharm. Sci. 4 (1996) 117-128.